| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.89B | +12.7% |
| R&D Expense | $57.0M | +46.2% |
| SG&A Expense | $275.0M | +21.7% |
| Interest Expense | $156.0M | +45.8% |
| Pre-tax Income | $289.0M | +149.5% |
| Income Tax | $265.0M | +40.2% |
| Net Income | $60.0M | +109.2% |
| EPS (Basic) | $0.26 | +107.1% |
| EPS (Diluted) | $0.26 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.14B | +20.6% |
| Accounts Receivable | $1.10B | +67.1% |
| Inventory | $2.00B | -7.4% |
| Current Assets | $4.91B | +11.6% |
| Total Assets | $14.06B | -0.6% |
| Current Liabilities | $3.40B | +12.0% |
| Long-term Debt | $2.54B | +40.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $622.0M | +583.5% |
| Capital Expenditures | $580.0M | +9.2% |
| Investing Cash Flow | -$608.0M | -3.9% |
| Financing Cash Flow | $201.0M | +252.6% |
| Free Cash Flow | $42.0M | +109.5% |
| +107.1% |
| Total Liabilities |
| $8.91B |
| +7.2% |
| Stockholders' Equity | $5.16B | +21.3% |